Philippe Zrounba

High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR

Souad Assaad, Virginie Avrillon, Marie‐Line Fournier et al. · European Journal of Cancer · 2020 · 124 citations · Full text

Medicine, Infectious Diseases, Oncology +6

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients

Jean‐Philippe Foy, Andy Karabajakian, Sandra Ortiz‐Cuaran et al. · European Journal of Cancer · 2022 · 66 citations

Life Sciences, Immunology, Oncology +17

Paclitaxel and cetuximab combination efficiency after the failure of a platinum-based chemotherapy in recurrent/metastatic head and neck squamous cell carcinoma

Julien Péron, Philippe Céruse, Emilie Lavergne et al. · Anti-Cancer Drugs · 2012 · 51 citations

Medicine, Oncology, Pharmacology +10

Prevalence and distribution of cervical lymph node metastases in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma

Laurence Bauwens, Aline Baltrès, Danny-Joe Fiani et al. · Radiotherapy and Oncology · 2021 · 50 citations

Medicine, Oncology, Cervical Disease +13

Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients

Jérôme Fayette, C. Fontaine-Delaruelle, A. Ambrun et al. · Oncotarget · 2016 · 39 citations · Full text

Medicine, Oncology, Pharmacology +12